Greg Koblentz, member of the Center’s Scientists Working Group of Chemical and Biological Threats, spoke with the New York Times about the lab-leak hypothesis and lab safety. “All along, discussion of lab safety has continued, but it’s often been the under-the-radar or behind-the-scenes kind that Filippa Lentzos of King’s College London — one of the leaders, […]
Op-Ed: Biology Is Dangerously Outpacing Policy
Gregory Koblentz, a member of the Center’s Scientists Working Group, co-authored an article for the New York Times about the need for greater government oversight on pathogen research in lab environments. “The original source of the coronavirus pandemic remains unconfirmed. While it was likely the result of a spillover from animals to humans, a lab […]
Expanding the Australia Group’s chemical weapons precursors control list with a family-based approach
Greg Koblentz and Stefano Costanzi, members of the Center’s Scientists Working Group on Biological and Chemical Security, co-authored an article in the journal Pure and Applied Chemistry recommending a family-based approach to controlling the spread of precursors used to make chemical weapons. This article is behind a paywall. Read more
Understanding Biosafety and Biosecurity in Ukraine
Greg Koblentz, member of the Center’s Scientists Working Group on Biological and Chemical Security, co-authored an article in the journal Health Security on biorisk management in Ukraine. The Russian invasion of Ukraine in February 2022 was accompanied by unfounded Russian allegations of bioweapon activities in Ukraine conducted by the United States and its allies. While false, […]
Expert Panel Votes for Stricter Rules on Risky Virus Research
Greg Koblentz, member of the Center’s Scientists Working Group of Chemical and Biological Threats, spoke with the New York Times about the government oversight over dangerous pathogens. “If the government implements the spirit of what they’ve written, this would be a major overhaul of dual-use research oversight in the United States,” said Gregory Koblentz, a biodefense […]